Skip to main content
Download PDF

Correction to: Hepatitis C virus infection in EU/EEA and United Kingdom prisons: Opportunities and challenges for action

BMC Public Health volume 23, Article number: 115 (2023) Cite this article

The Original Article was published on 09 November 2020

Correction to: BMC Public Health20, 1670 (2020).

https://doi.org/10.1186/s12889-020-09515-6.

The original publication of this article contained a typo in the results section of the abstract. The incorrect and correct information is shown below. The original article has been updated.

Incorrect

  • Seroprevalence of HCV antibodies ranged from 2·3% to 82·6% while viraemic infections ranged from 5·7% to 8·2%, where reported.

Correct

  • Seroprevalence of HCV antibodies ranged from 2·3% to 82·8% while viraemic infections ranged from 5·7–82%, where reported.

Author information

Authors and Affiliations

  1. Centre for Pharmacoepidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden

    Aya Olivia Nakitanda

  2. European Centre for Disease Prevention and Control, Stockholm, Sweden

    Aya Olivia Nakitanda & Erika Duffell

  3. European Monitoring Centre for Drugs and Drug Addiction, Lisbon, Portugal

    Linda Montanari

  4. Department of translational research and new technologies in medicine and surgery, University of Pisa, Pisa, Italy

    Lara Tavoschi

  5. World Health Organization Regional Office for Europe, Copenhagen, Denmark

    Antons Mozalevskis

Authors
  1. Aya Olivia Nakitanda
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Linda Montanari
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lara Tavoschi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Antons Mozalevskis
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Erika Duffell
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Aya Olivia Nakitanda.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The online version of the original article can be found at https://doi.org/10.1186/s12889-020-09515-6.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nakitanda, A.O., Montanari, L., Tavoschi, L. et al. Correction to: Hepatitis C virus infection in EU/EEA and United Kingdom prisons: Opportunities and challenges for action. BMC Public Health 23, 115 (2023). https://doi.org/10.1186/s12889-022-14317-z

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s12889-022-14317-z

BMC Public Health

ISSN: 1471-2458

Contact us